Helix Biopharma Corp Stock Analysis
| HBP Stock | CAD 0.87 0.07 7.45% |
Helix BioPharma Corp is overvalued with Real Value of 0.77 and Hype Value of 0.88. The main objective of Helix BioPharma stock analysis is to determine its intrinsic value, which is an estimate of what Helix BioPharma Corp is worth, separate from its market price. There are two main types of Helix BioPharma's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Helix BioPharma's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Helix BioPharma's stock to identify patterns and trends that may indicate its future price movements.
The Helix BioPharma stock is traded in Canada on Toronto Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Canada. Helix BioPharma is usually not traded on Canada Day, Civic Holiday, Labour Day, Thanksgiving Day, Christmas Day, Boxing Day, New Year 's Day, Family Day, Good Friday, Victoria Day. Helix Stock trading window is adjusted to America/Toronto timezone.
Helix |
Helix Stock Analysis Notes
The company recorded a loss per share of 1.05. Helix BioPharma Corp had not issued any dividends in recent years. The entity had 1:5 split on the 16th of August 2024. Helix BioPharma Corp., an immune-oncology company, focuses on the development of cancer drugs in Canada. Helix BioPharma Corp. is headquartered in Richmond Hill, Canada. HELIX BIOPHARM operates under Biotechnology classification in Canada and is traded on Toronto Stock Exchange. It employs 22 people. To learn more about Helix BioPharma Corp call Jacek Antas at 905-841-2300 or check out https://www.helixbiopharma.com.Helix BioPharma Corp Investment Alerts
| Helix BioPharma Corp generated a negative expected return over the last 90 days | |
| Helix BioPharma Corp has high historical volatility and very poor performance | |
| Helix BioPharma Corp has some characteristics of a very speculative penny stock | |
| Helix BioPharma Corp has high likelihood to experience some financial distress in the next 2 years | |
| Helix BioPharma Corp has accumulated 1.58 M in total debt. Helix BioPharma Corp has a current ratio of 0.36, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Helix BioPharma until it has trouble settling it off, either with new capital or with free cash flow. So, Helix BioPharma's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Helix BioPharma Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Helix to invest in growth at high rates of return. When we think about Helix BioPharma's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (9.26 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Helix BioPharma Corp has accumulated about 938 K in cash with (5.22 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. |
Helix Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 42.65 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Helix BioPharma's market, we take the total number of its shares issued and multiply it by Helix BioPharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 11th of December 2024, Helix BioPharma retains the Market Risk Adjusted Performance of (0.04), standard deviation of 8.28, and Risk Adjusted Performance of (0.01). Helix BioPharma technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.Helix BioPharma Corp Price Movement Analysis
The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Helix BioPharma middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Helix BioPharma Corp. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Helix BioPharma Outstanding Bonds
Helix BioPharma issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Helix BioPharma Corp uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Helix bonds can be classified according to their maturity, which is the date when Helix BioPharma Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View |
Helix BioPharma Predictive Daily Indicators
Helix BioPharma intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Helix BioPharma stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Daily Balance Of Power | (9,223,372,036,855) | |||
| Rate Of Daily Change | 0.93 | |||
| Day Median Price | 0.87 | |||
| Day Typical Price | 0.87 | |||
| Price Action Indicator | (0.04) | |||
| Period Momentum Indicator | (0.07) | |||
| Relative Strength Index | 46.38 |
Helix BioPharma Forecast Models
Helix BioPharma's time-series forecasting models are one of many Helix BioPharma's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Helix BioPharma's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Helix Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Helix BioPharma prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Helix shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Helix BioPharma. By using and applying Helix Stock analysis, traders can create a robust methodology for identifying Helix entry and exit points for their positions.
Helix BioPharma Corp., an immune-oncology company, focuses on the development of cancer drugs in Canada. Helix BioPharma Corp. is headquartered in Richmond Hill, Canada. HELIX BIOPHARM operates under Biotechnology classification in Canada and is traded on Toronto Stock Exchange. It employs 22 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Helix BioPharma to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Commodity Channel Now
Commodity ChannelUse Commodity Channel Index to analyze current equity momentum |
| All Next | Launch Module |
Other Information on Investing in Helix Stock
Helix BioPharma financial ratios help investors to determine whether Helix Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Helix with respect to the benefits of owning Helix BioPharma security.